Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience

Dosing regimens for antithymocyte globulin (ATG) and anti-CD52 antibody (alemtuzumab) for graft vs. host disease prophylaxis (GVHD) are empiric or weight-based, and do not account for individual patient factors. Recently, it has been shown that recipient peripheral blood absolute lymphocyte count (A...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Sheth, Vipul, Kennedy, Vanessa, de Lavallade, Hugues, Mclornan, Donal, Potter, Victoria, Engelhardt, Brian G., Savani, Bipin, Chinratanalab, Wichai, Goodman, Stacey, Greer, John, Kassim, Adetola, York, Sally, Kenyon, Michelle, Gandhi, Shreyans, Kulasekararaj, Austin, Marsh, Judith, Mufti, Ghulam, Pagliuca, Antonio, Jagasia, Madan, Raj, Kavita
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2019
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636242/
https://ncbi.nlm.nih.gov/pubmed/31355140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00623
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi